Trial intelligence / Profile preview

DGMI vs Ginaton in Elderly Ischemic Stroke

NCT05169450Completed

Sponsor
Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Start
Jul 2013
Primary completion
Apr 2014
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of Ginkgo diterpene lactone meglumine in ischemic stroke (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Proportion of patients with Modified Rankin Scale (mRS) less than or equal to 1 at 90 days. Started Jul 2013; status: completed.

02

Drugs

Ginkgo diterpene lactone meglumine
03

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT05169450.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05169450.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call